Clinical Trial Update: Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing TAK-438 (vonoprazan) to lansoprazole (AG-1749) for the treatment of duodenal ulcers has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer

Drugs mentioned

• Lansoprazole (Lansoprazole)
• TAK-438 (vonoprazan) (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Duodenal Ulcer | Phase 3 | Status: COMPLETED